FDA Orders Seizure Of $6M In Products At Triad Plant

Law360, New York (April 6, 2011, 10:07 PM EDT) -- Federal marshals seized more than $6 million in over-the-counter drug products at a Wisconsin facility owned by Triad Group Inc. because of manufacturing violations, according to the U.S. Food and Drug Administration.

The seizure was ordered by the FDA after H&P Industries Inc., which shares an owner with Triad Group, failed to comply with good manufacturing practice regulations, according to the agency. The FDA said the products seized at the Hartland, Wis., facility included povidone-iodine and benzalkonium chloride antiseptic products, cough and cold remedies, nasal sprays,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.